Literature DB >> 19401378

Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism.

Edda Vignali1, Giuseppe Viccica, Daniele Diacinti, Filomena Cetani, Luisella Cianferotti, Elena Ambrogini, Chiara Banti, Romano Del Fiacco, John P Bilezikian, Aldo Pinchera, Claudio Marcocci.   

Abstract

CONTEXT: An increased risk of fracture in patients with primary hyperparathyroidism (PHPT) compared to the general population has been reported, but available data are controversial.
OBJECTIVE: The aim of the study was to evaluate the rate of vertebral fractures (VFs) by dual-energy x-ray absorptiometry in postmenopausal women with sporadic PHPT and compare the results with a control group. DESIGN AND
SETTING: A case-control study was performed at a referral center. PARTICIPANTS: A total of 150 consecutive patients and 300 healthy women matched for age and menopausal age participated in the study.
RESULTS: VFs were detected in 37 of 150 (24.6%) patients and 12 of 300 (4.0%) controls (P < 0.0001). The majority of VFs were mild. Stepwise multiple logistic regression analysis showed that in PHPT patients lumbar spine bone mineral density was the only variable independently associated with the prevalence of VFs (P = 0.003). The rate of fracture was higher in symptomatic (34.1%) than asymptomatic (21.1%) patients, but this difference was not statistically significant (P = 0.15). Among asymptomatic patients, fracture rate was significantly higher in those who met the criteria for parathyroidectomy (28.1%) than in those who did not (11.1%) (P = 0.03). Compared to controls, the fracture rate was significantly higher in patients with symptomatic and asymptomatic PHPT who met the criteria for surgery (P < 0.0001), but not in those who did not meet the criteria (P = 0.06).
CONCLUSIONS: VF rate is increased in postmenopausal women with PHPT compared to controls, independently of whether they are classified as symptomatic or asymptomatic. The question of whether the finding of mild morphometric VFs in the latter represents an indication for parathyroid surgery remains to be established.

Entities:  

Mesh:

Year:  2009        PMID: 19401378      PMCID: PMC3214277          DOI: 10.1210/jc.2008-2006

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

Review 1.  Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century.

Authors:  John P Bilezikian; John T Potts; Ghada El-Hajj Fuleihan; Michael Kleerekoper; Robert Neer; Munro Peacock; Jonas Rastad; Shonni J Silverberg; Robert Udelsman; Samuel A Wells
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures.

Authors:  R J Wilson; S Rao; B Ellis; M Kleerekoper; A M Parfitt
Journal:  Ann Intern Med       Date:  1988-12-15       Impact factor: 25.391

3.  The threshold of bone mineral density for vertebral fractures in female patients with primary hyperparathyroidism.

Authors:  Hiroshi Kaji; Mika Yamauchi; Kazuo Chihara; Toshitsugu Sugimoto
Journal:  Eur J Endocrinol       Date:  2005-09       Impact factor: 6.664

4.  Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism.

Authors:  P Vestergaard; C L Mollerup; V G Frøkjaer; P Christiansen; M Blichert-Toft; L Mosekilde
Journal:  BMJ       Date:  2000-09-09

5.  Graphic trace analysis of ultrasound at the phalanges may differentiate between subjects with primary hyperparathyroidism and with osteoporosis: a pilot study.

Authors:  A Montagnani; S Gonnelli; C Cepollaro; D Bruni; M B Franci; B Lucani; C Gennari
Journal:  Osteoporos Int       Date:  2002-03       Impact factor: 4.507

6.  Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation.

Authors:  Filomena Cetani; Elena Pardi; Simona Borsari; Massimo Tonacchera; Eugenia Morabito; Aldo Pinchera; Claudio Marcocci; Glada Dipollina
Journal:  Clin Endocrinol (Oxf)       Date:  2003-02       Impact factor: 3.478

7.  Back pain and vertebral crush fractures: an unemphasized mode of presentation for primary hyperparathyroidism.

Authors:  R T Dauphine; B L Riggs; D A Scholz
Journal:  Ann Intern Med       Date:  1975-09       Impact factor: 25.391

8.  Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients.

Authors:  Peter Vestergaard; Leif Mosekilde
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

9.  What is the clinical significance of bone loss in primary hyperparathyroidism?

Authors:  G Kochersberger; N J Buckley; G S Leight; S Martinez; S Studenski; J Vogler; K W Lyles
Journal:  Arch Intern Med       Date:  1987-11

10.  Increased fracture risk in hypercalcemia. Bone mineral content measured in hyperparathyroidism.

Authors:  K Larsson; E Lindh; L Lind; I Persson; S Ljunghall
Journal:  Acta Orthop Scand       Date:  1989-06
View more
  49 in total

Review 1.  Catabolic and anabolic actions of parathyroid hormone on the skeleton.

Authors:  B C Silva; A G Costa; N E Cusano; S Kousteni; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

Review 2.  Utility of the trabecular bone score (TBS) in secondary osteoporosis.

Authors:  Fabio M Ulivieri; Barbara C Silva; Francesco Sardanelli; Didier Hans; John P Bilezikian; Renata Caudarella
Journal:  Endocrine       Date:  2014-05-23       Impact factor: 3.633

3.  Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology.

Authors:  Cristiana Cipriani; Federica Biamonte; Aline G Costa; Chiyuan Zhang; Piergianni Biondi; Daniele Diacinti; Jessica Pepe; Sara Piemonte; Alfredo Scillitani; Salvatore Minisola; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2015-02-03       Impact factor: 5.958

Review 4.  Hyperparathyroidism and Bone Health.

Authors:  Francisco Bandeira; Sara Cassibba
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

5.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

6.  Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.

Authors:  Cristiana Cipriani; Alice Abraham; Barbara C Silva; Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chengchen Zhang; Didier Hans; Shonni J Silverberg; John P Bilezikian
Journal:  Endocrine       Date:  2016-10-18       Impact factor: 3.633

7.  Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.

Authors:  Emily M Stein; Barbara C Silva; Stephanie Boutroy; Bin Zhou; Ji Wang; Julia Udesky; Chiyuan Zhang; Donald J McMahon; Megan Romano; Elzbieta Dworakowski; Aline G Costa; Natalie Cusano; Dinaz Irani; Serge Cremers; Elizabeth Shane; X Edward Guo; John P Bilezikian
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

Review 8.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

9.  Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.

Authors:  M D Walker; I Saeed; J A Lee; C Zhang; D Hans; T Lang; S J Silverberg
Journal:  Osteoporos Int       Date:  2016-05-19       Impact factor: 4.507

10.  Trabecular bone score (TBS)--a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism.

Authors:  Barbara Campolina Silva; Stephanie Boutroy; Chiyuan Zhang; Donald Jay McMahon; Bin Zhou; Ji Wang; Julia Udesky; Serge Cremers; Marta Sarquis; Xiang-Dong Edward Guo; Didier Hans; John Paul Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2013-03-22       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.